Compagnie Lombard Odier SCmA’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.3K | Sell |
|
|||||
|
2025
Q1 | $53.8K | Buy |
|
|||||
|
2022
Q4 | – | Hold |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $8K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $20K | Buy |
|
|||||
|
2021
Q1 | $9K | Hold |
|
|||||
|
2020
Q4 | $8K | Hold |
|
|||||
|
2020
Q3 | $7K | Sell |
|
|||||
|
2020
Q2 | $42K | Buy |
|
|||||
|
2020
Q1 | $7K | Sell |
|
|||||
|
2019
Q4 | $96K | Hold |
|
|||||
|
2019
Q3 | $68K | Buy |
|
|||||
|
2019
Q2 | $34K | Sell |
|
|||||
|
2019
Q1 | $844K | Hold |
|
|||||
|
2018
Q4 | $829K | Sell |
|
|||||
|
2018
Q3 | $5.47M | Buy |
|
|||||
|
2018
Q2 | $6.13M | Hold |
|
|||||
|
2018
Q1 | $4.31M | Sell |
|
|||||
|
2017
Q4 | $10.3M | Buy |
|
|||||
|
2017
Q3 | $4.79M | Buy |
|
|||||
|
2017
Q2 | $8.44M | Buy |
|
|||||
|
2017
Q1 | $2.38M | Buy |
|
|||||
|
2016
Q4 | $1.98M | Buy |
|
|||||
|
2016
Q3 | $172K | Sell |
|
|||||
|
2016
Q2 | $373K | Buy |
|
|||||
|
2016
Q1 | $264K | Sell |
|
|||||
|
2015
Q4 | $772K | Sell |
|
|||||
|
2015
Q3 | $867K | Buy |
|
|||||
|
2015
Q2 | $652K | Buy |
|
|||||
|
2015
Q1 | $682K | Buy |
|
|||||
|
2014
Q4 | $413K | Sell |
|
|||||
|
2014
Q3 | $570K | Sell |
|
|||||
|
2014
Q2 | $684K | Sell |
|
|||||
|
2014
Q1 | $2.81M | Sell |
|
|||||
|
2013
Q4 | $3.34M | Buy |
|